Clinical Trials Browser

OTHER × avelumab × Other solid neoplasm × Clear all

Solid Tumor

NCT03399552 2023-10-23

Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma

Phase 1/2 Completed

15 enrolled 8 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT05429866 2023-03-08

Immunological Variables Associated to ICI Toxicity in Cancer Patients

Phase 2 Unknown

441 enrolled

BreastDermatologicGastrointestinalGenitourinaryHead & NeckOther solid neoplasmThoracic

Mesothelioma, Malignant, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma

NCT03491345 2022-08-09

K-Basket, Avelumab, Biomarker-driven, Advanced Solid Tumor

Phase 2 Unknown

60 enrolled

Other solid neoplasm

PD-L1 Positive Mutation Tumor

Clinical Trials

myDAvIpNi

Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma

Immunological Variables Associated to ICI Toxicity in Cancer Patients

K-Basket, Avelumab, Biomarker-driven, Advanced Solid Tumor